Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
05/01/2009 | 23:00 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:PRW | Pro-Pharmaceuticals, |
31/12/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals Provides Year-End Update | AMEX:PRW | Pro-Pharmaceuticals, |
20/11/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals Files Registration Statement for Rights Offering to Its Shareholders | AMEX:PRW | Pro-Pharmaceuticals, |
19/11/2008 | 23:23 | Edgar (US Regulatory) | Securities Registration Statement (S-1) | AMEX:PRW | Pro-Pharmaceuticals, |
14/11/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals to Commence Rights Offering to Shareholders | AMEX:PRW | Pro-Pharmaceuticals, |
13/11/2008 | 22:15 | Business Wire | Pro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext US | AMEX:PRW | Pro-Pharmaceuticals, |
07/11/2008 | 13:30 | Business Wire | Pro-Pharmaceuticals Reports Third Quarter Results | AMEX:PRW | Pro-Pharmaceuticals, |
07/11/2008 | 13:17 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:PRW | Pro-Pharmaceuticals, |
06/11/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment Conference | AMEX:PRW | Pro-Pharmaceuticals, |
06/10/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDA | AMEX:PRW | Pro-Pharmaceuticals, |
23/09/2008 | 17:27 | Edgar (US Regulatory) | Pro Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:PRW | Pro-Pharmaceuticals, |
18/09/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals' Management Outlines Strategic Initiatives | AMEX:PRW | Pro-Pharmaceuticals, |
28/08/2008 | 13:00 | Business Wire | FDA Grants IND for Pro-Pharmaceuticals' DAVANAT(R) to Treat Breast Cancer Patient | AMEX:PRW | Pro-Pharmaceuticals, |
08/08/2008 | 13:10 | Edgar (US Regulatory) | Pro Pharmaceuticals Inc - Current report filing (8-K) | AMEX:PRW | Pro-Pharmaceuticals, |
08/08/2008 | 13:05 | Business Wire | Pro-Pharmaceuticals Reports Second Quarter Results | AMEX:PRW | Pro-Pharmaceuticals, |
08/08/2008 | 12:55 | Edgar (US Regulatory) | Pro Pharmaceuticals Inc - Quarterly Report (10-Q) | AMEX:PRW | Pro-Pharmaceuticals, |
06/08/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals Granted Pre-IND Meeting for Anti-Hypoxia Drug | AMEX:PRW | Pro-Pharmaceuticals, |
04/08/2008 | 13:00 | Business Wire | Amex Accepts Pro-Pharmaceuticals Compliance Plan | AMEX:PRW | Pro-Pharmaceuticals, |
15/07/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals Has Requested a Pre-IND Meeting with the U.S. Food and Drug Administration | AMEX:PRW | Pro-Pharmaceuticals, |
11/07/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals' Senior Executives to Be Featured on PBS' "Wealth & Wisdom" | AMEX:PRW | Pro-Pharmaceuticals, |
10/07/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals Appoints Noted Pioneer in Liver Diseases, Scott L. Friedman, M.D., to Scientific Advisory Board | AMEX:PRW | Pro-Pharmaceuticals, |
09/07/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals and Sanghyon Chemical Ink Historic Agency Agreement | AMEX:PRW | Pro-Pharmaceuticals, |
25/06/2008 | 13:00 | Business Wire | Pro-Pharmaceuticals' Executives Contribute to Definitive Book on Galectins | AMEX:PRW | Pro-Pharmaceuticals, |
20/06/2008 | 15:20 | Edgar (US Regulatory) | Pro Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | AMEX:PRW | Pro-Pharmaceuticals, |
20/06/2008 | 12:00 | Edgar (US Regulatory) | Pro Pharmaceuticals Inc - Notice of Effectiveness (EFFECT) | AMEX:PRW | Pro-Pharmaceuticals, |
10/06/2008 | 13:02 | Edgar (US Regulatory) | Pro Pharmaceuticals Inc - Withdrawal of Registration Statement (RW) | AMEX:PRW | Pro-Pharmaceuticals, |
29/05/2008 | 15:06 | Business Wire | Pro-Pharmaceuticals, Inc. Retains the Investor Relations Group | AMEX:PRW | Pro-Pharmaceuticals, |
21/05/2008 | 12:00 | Business Wire | Pro-Pharmaceuticals Issues Letter to Shareholders | AMEX:PRW | Pro-Pharmaceuticals, |
20/05/2008 | 13:30 | Business Wire | Pro-Pharmaceuticals Announces Submission of Drug Master File for DAVANAT(R) to FDA | AMEX:PRW | Pro-Pharmaceuticals, |
20/05/2008 | 12:30 | Business Wire | Pro-Pharmaceuticals Receives Amex Non-Compliance Notice | AMEX:PRW | Pro-Pharmaceuticals, |